Larvol Delta - Candel-Therapeutics-Announces-Initiation-of-Global-Pivotal-Phase-3-AURORA-Trial-Evaluating-Aglatimagene-Besadenovec-CAN2409-in-Advanced-NonSmall-Cell-Lung-Cancer-Patients-with-Inadequate-Response-to-Immune-Checkpoint-Inhibitors

ProstAtak (aglatimagene besadenovec) - Candel Therap

https://www.manilatimes.net/2026/06/30/tmt-newswire/globenewswire/candel-therapeutics-announces-initiation-of-global-pivotal-phase-3-aurora-trial-evaluating-aglatimagene-besadenovec-can-2409-in-advanced-non-small-cell-lung-cancer-patients-with-inadequate-response-to-immune-checkpoint-inhibitors/2375759

Jun 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next